By 2026, the bone marrow-derived tissue cells in musculoskeletal medicine should see a major shift. Ongoing trials suggest promise for managing multiple orthopedic conditions, like joint deterioration, tendon pain, https://regenstep.com/stem-cell-therapy-2026-proven-vs-fiction/